Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine

BACKGROUND: Combination chemotherapy with mitomycin C and methotrexate (MM) was reported to be effective for 24% of patients with metastatic breast cancer (MBC) who had been treated with anthracycline and taxane. Antimetabolites such as capecitabine and antitubulins such as vinorelbine have been gen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Springerplus
Main Authors: Fukuda, Takayo, Tanabe, Masahiko, Kobayashi, Kokoro, Fukada, Ippei, Takahashi, Shunji, Iwase, Takuji, Ito, Yoshinori
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4514730/
https://ncbi.nlm.nih.gov/pubmed/26217553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-1159-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados